Traynor Capital Management, Inc. Kazia Therapeutics LTD Transaction History

Traynor Capital Management, Inc.

  • $1.47 Billion
  • Q4 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$0.19 - $1.24 $1,900 - $12,400
10,000 New
10,000 $4,000

Others Institutions Holding KZIA

# of Institutions
7
Shares Held
371K
Call Options Held
78.8K
Put Options Held
0
View Full List

About KAZIA THERAPEUTICS LTD

KZIA Quotes by TradingView
  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $13.4M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Traynor Capital Management, Inc. Portfolio

Follow Traynor Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email